Shopping Cart 0
Cart Subtotal
AED 0

Partners Innovation Fund LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 2753

Details

Summary

Partners Innovation Fund LLC (PIF), a subsidiary of Partners HealthCare System Inc focuses to invest in healthcare companies based on intellectual property created within its research community. The company provides capital to seed and early stage medical devices, diagnostics, digital health and drug development companies. PIF specializes in offering finance and support to its portfolio companies through their complete financing lifecycles. The company's portfolio companies include Abcuro Inc, Life Image Inc, Tilos Therapeutics Inc, Sebacia Inc, SwanBio Therapeutics Ltd, and Syntimmune Inc among others. PIF is headquartered in Cambridge, Massachusetts, the US.

Partners Innovation Fund LLC-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Partners Innovation Fund LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Partners Innovation Fund LLC, Medical Devices Deals, 2012 to YTD 2018 9

Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deal Details 12

Venture Financing 12

Akouos Raises USD50 Million in Series A Financing 12

SwanBio Therapeutics Raises USD25 Million in First Tranche of Series A Venture financing 14

Akouos Raises USD7.5 Million in Seed Financing 15

Magenta Therapeutics Raises USD50 Million in Series B Financing 16

Syntimmune Raises USD8 Million in Final Tranche of Series A Financing Round 18

ImmuneXcite Raises USD8.6 Million in Series A-1 Financing 19

Syntimmune Raises USD10 Million in Second Tranche of Series A Financing Round 20

Spero Therapeutics Raises USD30 Million in Series B Funding 21

Editas Medicine Raises USD120 Million in Series B Financing 23

Spero Therapeutics Raises USD30 Million in Extended Series A Financing 26

Lysosomal Therapeutics Raises USD20 Million in Series A Financing 28

Quartet Medicine Raises USD17 Million in Series A Venture Financing 30

Raze Therapeutics Raises USD24 Million in Series A Venture Financing 31

Lysosomal Therapeutics Raises USD 4.8 Million In Seed Financing 33

Spero Therapeutics Raises USD3 Million in Series A Venture Financing 35

Editas Medicine Raises USD 43 Million In Series A Financing 36

Annovation BioPharma Raises USD 8 Million In Series A Financing 38

RaNA Therapeutics Raises Additional USD 18 Million In Series A Financing 39

Acquisition 41

Novartis Acquires CoStim Pharma 41

Partners Innovation Fund LLC-Key Competitors 43

Partners Innovation Fund LLC-Key Employees 44

Partners Innovation Fund LLC-Locations And Subsidiaries 45

Head Office 45

Appendix 46

Methodology 46

About GlobalData 46

Contact Us 46

Disclaimer 46


List Of Figure

List of Figures

Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Partners Innovation Fund LLC, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Key Facts 2

Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Partners Innovation Fund LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Partners Innovation Fund LLC, Deals By Therapy Area, 2012 to YTD 2018 8

Partners Innovation Fund LLC, Medical Devices Deals, 2012 to YTD 2018 9

Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Akouos Raises USD50 Million in Series A Financing 12

SwanBio Therapeutics Raises USD25 Million in First Tranche of Series A Venture financing 14

Akouos Raises USD7.5 Million in Seed Financing 15

Magenta Therapeutics Raises USD50 Million in Series B Financing 16

Syntimmune Raises USD8 Million in Final Tranche of Series A Financing Round 18

ImmuneXcite Raises USD8.6 Million in Series A-1 Financing 19

Syntimmune Raises USD10 Million in Second Tranche of Series A Financing Round 20

Spero Therapeutics Raises USD30 Million in Series B Funding 21

Editas Medicine Raises USD120 Million in Series B Financing 23

Spero Therapeutics Raises USD30 Million in Extended Series A Financing 26

Lysosomal Therapeutics Raises USD20 Million in Series A Financing 28

Quartet Medicine Raises USD17 Million in Series A Venture Financing 30

Raze Therapeutics Raises USD24 Million in Series A Venture Financing 31

Lysosomal Therapeutics Raises USD 4.8 Million In Seed Financing 33

Spero Therapeutics Raises USD3 Million in Series A Venture Financing 35

Editas Medicine Raises USD 43 Million In Series A Financing 36

Annovation BioPharma Raises USD 8 Million In Series A Financing 38

RaNA Therapeutics Raises Additional USD 18 Million In Series A Financing 39

Novartis Acquires CoStim Pharma 41

Partners Innovation Fund LLC, Key Competitors 43

Partners Innovation Fund LLC, Key Employees 44

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Partners Innovation Fund LLC, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Partners Innovation Fund LLC (PIF), a subsidiary of Partners HealthCare System Inc focuses to invest in healthcare companies based on intellectual property created within its research community. The company provides capital to seed and early stage medical devices, diagnostics, digital health and drug development companies. PIF specializes in offering finance and support to its portfolio companies through their complete financing lifecycles. The company's portfolio companies include Abcuro Inc, Life Image Inc, Tilos Therapeutics Inc, Sebacia Inc, SwanBio Therapeutics Ltd, and Syntimmune Inc among others. PIF is headquartered in Cambridge, Massachusetts, the US.

Partners Innovation Fund LLC-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Partners Innovation Fund LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Partners Innovation Fund LLC, Medical Devices Deals, 2012 to YTD 2018 9

Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deal Details 12

Venture Financing 12

Akouos Raises USD50 Million in Series A Financing 12

SwanBio Therapeutics Raises USD25 Million in First Tranche of Series A Venture financing 14

Akouos Raises USD7.5 Million in Seed Financing 15

Magenta Therapeutics Raises USD50 Million in Series B Financing 16

Syntimmune Raises USD8 Million in Final Tranche of Series A Financing Round 18

ImmuneXcite Raises USD8.6 Million in Series A-1 Financing 19

Syntimmune Raises USD10 Million in Second Tranche of Series A Financing Round 20

Spero Therapeutics Raises USD30 Million in Series B Funding 21

Editas Medicine Raises USD120 Million in Series B Financing 23

Spero Therapeutics Raises USD30 Million in Extended Series A Financing 26

Lysosomal Therapeutics Raises USD20 Million in Series A Financing 28

Quartet Medicine Raises USD17 Million in Series A Venture Financing 30

Raze Therapeutics Raises USD24 Million in Series A Venture Financing 31

Lysosomal Therapeutics Raises USD 4.8 Million In Seed Financing 33

Spero Therapeutics Raises USD3 Million in Series A Venture Financing 35

Editas Medicine Raises USD 43 Million In Series A Financing 36

Annovation BioPharma Raises USD 8 Million In Series A Financing 38

RaNA Therapeutics Raises Additional USD 18 Million In Series A Financing 39

Acquisition 41

Novartis Acquires CoStim Pharma 41

Partners Innovation Fund LLC-Key Competitors 43

Partners Innovation Fund LLC-Key Employees 44

Partners Innovation Fund LLC-Locations And Subsidiaries 45

Head Office 45

Appendix 46

Methodology 46

About GlobalData 46

Contact Us 46

Disclaimer 46


List Of Figure

List of Figures

Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Partners Innovation Fund LLC, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Key Facts 2

Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Partners Innovation Fund LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Partners Innovation Fund LLC, Deals By Therapy Area, 2012 to YTD 2018 8

Partners Innovation Fund LLC, Medical Devices Deals, 2012 to YTD 2018 9

Partners Innovation Fund LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Akouos Raises USD50 Million in Series A Financing 12

SwanBio Therapeutics Raises USD25 Million in First Tranche of Series A Venture financing 14

Akouos Raises USD7.5 Million in Seed Financing 15

Magenta Therapeutics Raises USD50 Million in Series B Financing 16

Syntimmune Raises USD8 Million in Final Tranche of Series A Financing Round 18

ImmuneXcite Raises USD8.6 Million in Series A-1 Financing 19

Syntimmune Raises USD10 Million in Second Tranche of Series A Financing Round 20

Spero Therapeutics Raises USD30 Million in Series B Funding 21

Editas Medicine Raises USD120 Million in Series B Financing 23

Spero Therapeutics Raises USD30 Million in Extended Series A Financing 26

Lysosomal Therapeutics Raises USD20 Million in Series A Financing 28

Quartet Medicine Raises USD17 Million in Series A Venture Financing 30

Raze Therapeutics Raises USD24 Million in Series A Venture Financing 31

Lysosomal Therapeutics Raises USD 4.8 Million In Seed Financing 33

Spero Therapeutics Raises USD3 Million in Series A Venture Financing 35

Editas Medicine Raises USD 43 Million In Series A Financing 36

Annovation BioPharma Raises USD 8 Million In Series A Financing 38

RaNA Therapeutics Raises Additional USD 18 Million In Series A Financing 39

Novartis Acquires CoStim Pharma 41

Partners Innovation Fund LLC, Key Competitors 43

Partners Innovation Fund LLC, Key Employees 44

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Partners Innovation Fund LLC, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.